Knowledge Hub
A structured library of practical guidance across GMP compliance, investigations, documentation, audits, supplier quality, and risk-based decision-making.
VerethiQ organizes pharmaceutical quality systems into six connected domains to support clearer execution, stronger compliance, and better operational decisions across regulated environments.
Case Study: Supplier Risk Failure
The GMP case study demonstrates how failure to reassess supplier risk can allow warning signals to accumulate until a significant supplier quality event occurrs.
Case Study: OOS Investigation Using FMEA
This GMP case study demonstrates how FMEA can strengthen OOS investigations by evaluating failure pathways, detectability, recurrence trends, and corrective action effectiveness.
Using QRM Data for Predictive Analysis
Predictive quality management uses QRM data, trends, and leading indicators to identify emerging vulnerabilities and support proactive risk-based decision-making.
Bayesian Approaches for Quality Systems
Bayesian risk thinking helps GMP organizations update risk conclusions as new evidence emerges, improving investigations, governance, and proactive quality oversight.
Risk-Based Training Systems
Risk-based training systems help GMP organizations align qualification depth, effectiveness verification, and oversight intensity with actual operational exposure and human performance risk.
Risk-Based Batch Disposition
Risk-based batch disposition helps GMP organizations align release decisions with actual operational exposure, uncertainty, detectability decisions, and control reliability.
Risk-Based Change Control
Risk-based change control helps GMP organizations apply proportional oversight based on actual operational exposure, uncertainty, and implementation risk.
Scoring Audit Findings
Risk-based scoring of audit findings helps GMP organizations prioritize escalation, CAPA depth, and oversight intensity based on actual operational significance and system vulnerability.
Risk-Based Audit Planning
Risk-based audit planning helps GMP organizations align audit scope, frequency, and oversight depth with actual operational exposure and evolving system risk.
Applying FMEA During Investigations
FMEA helps GMP investigations evaluate failure pathways, detectability limitations, recurrence patterns, and broader operational vulnerabilities beyond isolated symptom review.
Risk-Based CAPA
Risk-based CAPA helps GMP organizations align corrective action depth, verification, and oversight with actual operational exposure and recurrence risk.
Using QRM to Prioritize Deviations
Risk-based deviation prioritization helps GMP organizations align investigation depth, escalation, and oversight with actual operational exposure rather than administrative classification alone.